Bristol-Myers Squibb (BMY)

54.77 +0.35 (0.64%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/31/19)
- M&A (9/30/19 *Est)

Latest Headlines

Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at UBS October 23, 2019 5:37 AM - StreetInsider Bristol-Myers Squibb (BMY) CheckMate -9LA Meets Primary Endpoint Demonstrating Superior OS Compared to Chemotherapy Alone in First-Line Lung Cancer October 22, 2019 7:06 AM - StreetInsider CheckMate -9LA, a Phase 3 Trial Evaluating Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Combined with Chemotherapy, Meets Primary Endpoint Demonstrating Superior Overall Survival Compared to C October 22, 2019 6:59 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: Oct 18 October 18, 2019 8:01 AM - SEC Filing Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes October 18, 2019 6:59 AM - BizWire UPDATE: UPDATE: BofA/Merrill Lynch Reinstates Bristol-Myers Squibb Co. (BMY) at Buy October 16, 2019 4:30 PM - StreetInsider Kitov Pharma (KTOV) Announces Amended Marketing and Distribution Agreement with Coeptis, Provides Update on Launch of Consensi in U.S October 11, 2019 8:55 AM - StreetInsider Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch of Consensi™ in the U.S October 11, 2019 8:55 AM - StreetInsider Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch of Consensi™ in the U.S October 11, 2019 8:53 AM - Globe NewsWire Bristol-Myers Squibb Co. (BMY) PT Raised to $50 at BofA/Merrill Lynch October 10, 2019 6:26 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Oct 08 October 8, 2019 8:01 AM - SEC Filing Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes October 8, 2019 6:59 AM - BizWire Proxy solicitor Okapi hires Harnett from Strategic Governance Advisors October 4, 2019 9:34 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Oct 02 Filed by: Biondi Paul October 3, 2019 4:47 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: Vousden Karen H October 2, 2019 4:55 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: Storch Gerald L October 2, 2019 4:54 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: Samuels Theodore R. II October 2, 2019 4:54 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: Paliwal Dinesh C October 2, 2019 4:53 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: LACY ALAN J October 2, 2019 4:53 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: GROBSTEIN MICHAEL October 2, 2019 4:53 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: Emmens Matthew October 2, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: BERTOLINI ROBERT J October 2, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Sep 30 Filed by: Arduini Peter J October 2, 2019 4:51 PM - SEC Filing Kitov Pharma (KTOV) Appoints Eric K. Rowinsky, M.D., as Chairman October 2, 2019 8:21 AM - StreetInsider Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board October 2, 2019 8:21 AM - StreetInsider Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board October 2, 2019 8:20 AM - Globe NewsWire Popular stocks with increasing unusual volume: BMY GPRO JD MDR ACB October 1, 2019 4:42 AM - StreetInsider Call Buying Activity in Bristol-Myers Squibb (BMY) Targets Long-Term Upside in Shares -Susquehanna September 30, 2019 2:52 PM - StreetInsider Bristol-Myers Squibb (BMY) call put ratio 12 calls to 1 put with focus on June 60 calls September 30, 2019 12:44 PM - StreetInsider Opdivo (nivolumab) Demonstrates Statistically Significant Overall Survival Benefit Versus Chemotherapy in Patients with Advanced Esophageal Cancer September 30, 2019 10:30 AM - BizWire Bristol-Myers Squibb Announces Final Results from CheckMate -227 Part 1 Demonstrating Superior Overall Survival for Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) vs. Chemotherapy in Advanced No September 28, 2019 10:30 AM - BizWire Adjuvant Treatment with Opdivo (nivolumab) Continues to Demonstrate Extended Recurrence-Free Survival at Three Years in Resected High-Risk Melanoma Patients September 28, 2019 2:30 AM - BizWire Five-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma September 28, 2019 2:30 AM - BizWire Bristol-Myers Squibb (BMY) Reports Positive CHMP Recommendation Approval of Opdivo (nivolumab) Flat Dosing Schedule September 24, 2019 7:01 AM - StreetInsider Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) Four-Week Dosing Schedule for the Adjuvant Treatment of Adult Patients with Melanoma with Involvement of September 24, 2019 6:59 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: Sep 23 September 23, 2019 8:02 AM - SEC Filing  Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes September 23, 2019 6:59 AM - BizWire Bristol-Myers Squibb to Hold Investor Webcast to Discuss ESMO Highlights September 20, 2019 6:59 AM - BizWire Bristol-Myers Squibb (BMY) Says Research at ESMO Demonstrates Breadth of Oncology Development Program and Focus on Improving OS Across Multiple Cancers September 19, 2019 7:00 AM - StreetInsider Bristol-Myers Squibb Research at ESMO Demonstrates Breadth of Oncology Development Program and Focus on Improving Overall Survival Across Multiple Cancers September 19, 2019 6:59 AM - BizWire Morgan Stanley retains billing as top adviser in activist fights: Refinitiv data September 16, 2019 1:43 PM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Sep 11 September 12, 2019 5:28 PM - SEC Filing Bristol-Myers Squibb to Announce Results for Third Quarter 2019 on October 31, 2019 September 12, 2019 6:59 AM - BizWire Bristol-Myers Squibb (BMY) Announces Election of Three New Directors September 11, 2019 5:40 PM - StreetInsider Bristol-Myers Squibb Board Announces Election of Three New Directors September 11, 2019 5:39 PM - BizWire Bristol-Myers Squibb (BMY) Declares $0.41 Quarterly Dividend; 3.3% Yield September 11, 2019 4:18 PM - StreetInsider Bristol‑Myers Squibb Announces Dividend September 11, 2019 4:16 PM - BizWire Bristol-Myers Squibb (BMY) Announces Pooled Five-Year Survival Results for Opdivo in Previously-Treated Advanced NSCLC September 10, 2019 6:16 AM - StreetInsider Bristol-Myers Squibb Announces Pooled Five-Year Survival Results for Opdivo (nivolumab) in Previously-Treated Advanced Non-Small Cell Lung Cancer Patients September 10, 2019 5:30 AM - BizWire Bristol-Myers Squibb Co. (BMY) Could Be Worth $100/Share Says Societe Generale September 9, 2019 8:42 AM - StreetInsider Kitov Pharma (KTOV) Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance September 9, 2019 8:32 AM - StreetInsider Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance September 9, 2019 8:32 AM - StreetInsider Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance September 9, 2019 8:30 AM - Globe NewsWire Bristol-Myers Squibb (BMY) Reports Update on Phase 3 Opdivo (nivolumab) CheckMate -548 Trial September 5, 2019 7:00 AM - StreetInsider IFM Therapeutics Announces Collaboration and Exclusive Option Agreement for cGAS/STING-Focused Subsidiary, IFM Due September 5, 2019 7:00 AM - PR NewsWire Bristol-Myers Squibb Provides Update on Phase 3 Opdivo (nivolumab) CheckMate -548 Trial in Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme September 5, 2019 6:59 AM - BizWire Press Release Biocartis NV: Biocartis announces H1 2019 results September 5, 2019 1:01 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Sep 01 Filed by: Santiago Karen Murphy September 4, 2019 5:18 PM - SEC Filing  More Than 100 Bristol-Myers Squibb Employees Embark on Coast 2 Coast 4 Cancer Ride to Help Advance Groundbreaking Cancer Research September 4, 2019 7:00 AM - BizWire BioMotiv and Bristol-Myers Squibb Form Strategic Partnership September 4, 2019 7:00 AM - BizWire Bristol-Myers Squibb Co. (BMY) PT Raised to $49 at BofA/Merrill Lynch September 3, 2019 8:37 AM - StreetInsider Bristol-Myers Squibb to Take Part at the Morgan Stanley Conference September 3, 2019 6:59 AM - BizWire Kitov Pharma to Present New Data on NT-219 Targeting Cancer Drug Resistance at the AACR Pancreatic Cancer: Advances in Science and Clinical Care Conference August 29, 2019 8:31 AM - StreetInsider Kitov Pharma to Present New Data on NT-219 Targeting Cancer Drug Resistance at the AACR Pancreatic Cancer: Advances in Science and Clinical Care Conference August 29, 2019 8:30 AM - Globe NewsWire European Commission Approves Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone (EPd) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma August 27, 2019 4:16 PM - BizWire UPDATE: Bristol-Myers Squibb (BMY), Presage Biosciences Announce Research Collaboration for Phase O Studies of Novel Cancer Agents Utilizing CIVO Technology August 27, 2019 8:03 AM - StreetInsider Presage Announces Collaboration with Bristol-Myers Squibb for Phase O Studies of Novel Cancer Agents Utilizing CIVO™ Technology August 27, 2019 8:00 AM - PR NewsWire Pre-Open Movers 08/26: (FBIO) (MDCO) (PBI) Higher (ALXN) (CREE) (AMGN) Lower (more...) August 26, 2019 9:28 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Aug 25 August 26, 2019 8:31 AM - SEC Filing Wall Street bounces as trade temperature cools August 26, 2019 8:00 AM - StreetInsider Bristol-Myers Squibb (BMY) Gains 5% on Celgene's Deal to Sell Otezla to Amgen August 26, 2019 6:50 AM - StreetInsider Bristol-Myers Squibb (BMY) Raises Accelerated Buyback to $7B, to De-Lever Balance Sheet August 26, 2019 6:37 AM - StreetInsider Amgen (AMGN) to Acquire Otezla from Celgene (CELG) for $13.4B August 26, 2019 6:32 AM - StreetInsider Amgen To Acquire Otezla® For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits August 26, 2019 6:30 AM - PR NewsWire Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion August 26, 2019 6:30 AM - BizWire Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal August 16, 2019 8:24 AM - Globe NewsWire Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal August 16, 2019 8:24 AM - StreetInsider Paulson's 13F Shows New Stakes in Sotheby's (BID), Lyft (LYFT), Increase in Allergan (AGN), Sprint (S) (more...) August 14, 2019 5:10 PM - StreetInsider Elliott Management Enters Marathon Petroleum (MPC) - 13F August 14, 2019 4:22 PM - StreetInsider Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority August 14, 2019 8:20 AM - Globe NewsWire Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority August 14, 2019 8:20 AM - StreetInsider Atlantic Equities Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight August 14, 2019 4:38 AM - StreetInsider Baupost's 13F Shows New Stake in XPO Logistics (XPO), Increase in Bristol-Myers Squibb (BMY), CBS (CBS), Liquidated Celgene (CELG) (More...) August 13, 2019 5:28 PM - StreetInsider Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update August 8, 2019 8:20 AM - Globe NewsWire Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update August 8, 2019 8:20 AM - StreetInsider PTC Therapeutics Expands Presence in New Jersey by Securing State-of-the-Art Biologics Facility August 5, 2019 8:00 AM - PR NewsWire Form 4 BRISTOL MYERS SQUIBB CO For: Jul 31 Filed by: BERTOLINI ROBERT J August 1, 2019 5:07 PM - SEC Filing Nektar (NKTR) and Bristol-Myers Squibb (BMY) Announce FDA Breakthrough Therapy Designation for Bempegaldesleukin with Opdivo for Treatment of Patients with Untreated Advanced Melanoma August 1, 2019 7:59 AM - StreetInsider Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo® (nivolumab) for the Treatment of Patients August 1, 2019 7:00 AM - PR NewsWire Celgene (CELG) Tops Q2 EPS by 23c, Raises Gudiance July 30, 2019 7:35 AM - StreetInsider Celgene Reports Second Quarter 2019 Operating and Financial Results July 30, 2019 7:30 AM - BizWire Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat July 30, 2019 7:13 AM - StreetInsider Bristol-Myers Squibb (BMY) Announces European Commission Approval of Pending Acquisition of Celgene (CELG) July 29, 2019 10:10 AM - StreetInsider Bristol-Myers Squibb Announces European Commission Approval of Pending Acquisition of Celgene July 29, 2019 10:10 AM - BizWire Pfizer to spinoff, merge off-patent drugs unit with Mylan July 29, 2019 7:01 AM - StreetInsider Bristol-Myers Squibb (BMY) Receives Positive CHMP Opinion Recommending Approval of Empliciti Plus Pomalidomide and Low-Dose Dexamethasone for Treatment of Patients with R/R MM July 26, 2019 7:06 AM - StreetInsider Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone for Treatment of Patients with Relapsed and Refractory July 26, 2019 6:59 AM - BizWire Active options: INTC BA F MSFT AMD TWTR T NVDA MU AMZN BMY DIS July 26, 2019 4:32 AM - StreetInsider Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30 July 25, 2019 11:35 AM - SEC Filing Eliquis, Orencia sales propel Bristol-Myers to strong second quarter July 25, 2019 10:35 AM - StreetInsider Pre-Open Movers 07/25: (DBD) (NTGR) (MTH) Higher; (ALGN) (SAVE) (PTC) (more...) July 25, 2019 9:16 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Jul 25 July 25, 2019 8:21 AM - SEC Filing Bristol-Myers Squibb (BMY) Tops Q2 EPS by 12c, Raises FY Guidance July 25, 2019 7:02 AM - StreetInsider Bristol-Myers Squibb Reports Second Quarter Financial Results July 25, 2019 6:59 AM - BizWire Options expected to have increasing volume: BMY PYPL ALGN BUD July 25, 2019 4:36 AM - StreetInsider Full Article List